Literature DB >> 1370948

Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes.

L J Zhou1, D C Ord, S A Omori, T F Tedder.   

Abstract

CD19 is a B lymphocyte cell-surface marker that is expressed early during pre-B-cell differentiation with expression persisting until terminal differentiation into plasma cells. CD19 is a member of the Ig gene superfamily with two extracellular Ig-like domains separated by a non-Ig-like domain, and with an extensive approximately 240 amino acid cytoplasmic domain. In this study, Southern blot analysis revealed that the human and mouse CD19 genes were compact single copy genes. Both the human and mouse CD19 genes were isolated and the nucleotide sequences flanking each exon were determined. Both genes were composed of 15 exons and spanned approximately 8 kilobases (kb) of DNA in human and approximately 6 kb in mouse. The positions of exon-intron boundaries were identical between human and mouse and correlated with the putative functional domains of the CD19 protein. The 200 bp region 5' of the putative translation initiation AUG codon was well conserved in sequence between human and mouse and contained potential transcription regulatory elements. In addition, the 3' untranslated regions (UT) of the CD19 genes following the termination codon were conserved in sequence. The high level of conservation of nucleotide sequences between species in all exons and 5' and 3' UT suggests that expression of the CD19 gene may be regulated in a similar fashion in human and mouse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370948     DOI: 10.1007/bf00189519

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  34 in total

1.  Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.

Authors:  T A Libermann; M Lenardo; D Baltimore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 2.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

3.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  Immunoglobulin enhancer and promoter motifs 5' of the B29 B-cell-specific gene.

Authors:  G G Hermanson; M Briskin; D Sigman; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1).

Authors:  T F Tedder; G Klejman; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

7.  Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation.

Authors:  K C Anderson; M P Bates; B L Slaughenhoupt; G S Pinkus; S F Schlossman; L M Nadler
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

8.  Structure of the murine mb-1 gene encoding a putative sIgM-associated molecule.

Authors:  S Kashiwamura; T Koyama; T Matsuo; M Steinmetz; M Kimoto; N Sakaguchi
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

9.  Expression of cell surface markers after human B lymphocyte activation.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

10.  B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

Authors:  L M Nadler; K C Anderson; G Marti; M Bates; E Park; J F Daley; S F Schlossman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

View more
  11 in total

Review 1.  CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas.

Authors:  Alexandra S Onea; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

2.  RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke.

Authors:  Se-Ran Yang; Hongwei Yao; Saravanan Rajendrasozhan; Sangwoon Chung; Indika Edirisinghe; Samantha Valvo; George Fromm; Michael J McCabe; Patricia J Sime; Richard P Phipps; Jian-Dong Li; Michael Bulger; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

3.  Multiple motifs regulate the B-cell-specific promoter of the B29 gene.

Authors:  S A Omori; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

4.  CD19 maps to a region of conservation between human chromosome 16 and mouse chromosome 7.

Authors:  D C Ord; S Edelhoff; H Dushkin; L J Zhou; D R Beier; C Disteche; T F Tedder
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development.

Authors:  L J Zhou; H M Smith; T J Waldschmidt; R Schwarting; J Daley; T F Tedder
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice.

Authors:  Chengming Wang; Frederik W van Ginkel; Teayoun Kim; Dan Li; Yihang Li; John C Dennis; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

7.  Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization.

Authors:  A M Buhl; C M Pleiman; R C Rickert; J C Cambier
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

8.  Cloning and Expression of CD19, a Human B-Cell Marker in NIH-3T3 Cell Line.

Authors:  Hajar Abbasi-Kenarsari; Farzaneh Shafaghat; Behzad Baradaran; Ali Akbar Movassaghpour; Dariush Shanehbandi; Tohid Kazemi
Journal:  Avicenna J Med Biotechnol       Date:  2015 Jan-Mar

9.  CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.

Authors:  Kemeng Wang; Guoqing Wei; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2012-11-29

Review 10.  EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma.

Authors:  Irene Papadouli; Jan Mueller-Berghaus; Claire Beuneu; Sahra Ali; Benjamin Hofner; Frank Petavy; Kyriaki Tzogani; Anne Miermont; Koenraad Norga; Olga Kholmanskikh; Tim Leest; Martina Schuessler-Lenz; Tomas Salmonson; Christian Gisselbrecht; Jordi Llinares Garcia; Francesco Pignatti
Journal:  Oncologist       Date:  2020-04-27       Impact factor: 5.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.